Table 2 The immunomodulatory treatments the analyzed patients underwent after blood sampling.
From: Prediction of acute multiple sclerosis relapses by transcription levels of peripheral blood cells
|  | CIS | Definite MS | Non treated patients | Interferon β-1a Avonex | Interferon β-1b Betaferon | Interferon β-1a Rebif | Glatiramer acetate Copaxone | Intravenous Immunoglobulins Iv-Ig |
|---|---|---|---|---|---|---|---|---|
No of Patients | 32 | 62 | 61 | 5 | 2 | 10 | 10 | 6 |